Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients

Esther M. de Kruijf(Leiden University Medical Center), Wilma E. Mesker(Leiden University Medical Center), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Peter J.K. Kuppen(Leiden University Medical Center), Hein Putter, Vincent T.H.B.M. Smit(Leiden University Medical Center), Cornelis J.�H. van de Velde(Leiden University Medical Center), Johanna G. H. van Nes(Leiden University Medical Center), Gerrit‐Jan Liefers(Leiden University Medical Center)
Breast Cancer Research and Treatment
April 1, 2010
Cited by 287


Related Papers